Literature DB >> 7835931

Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19.

P H Elzer1, R H Jacobson, S M Jones, K H Nielsen, J T Douglas, A J Winter.   

Abstract

In BALB/c mice antibodies specific for the O polysaccharide (OPS) as well as T lymphocytes mediate protective immunity to Brucella abortus. We performed quantitative analyses of isotypes of OPS antibodies generated during primary infections, and tested the protective qualities of antisera at successive stages of infection against B. abortus strain 2308, representative of the wild type, and attenuated vaccine strain 19. IgM antibodies predominated during the first 3-4 weeks of infection. IgG3 antibodies increased slowly for the first 3 weeks but then rose rapidly and persisted at high levels (> 300 micrograms/ml). IgG1, IgG2a and IgG2b antibodies had increased slightly by week 4 and then remained at low to moderate levels (< 70 micrograms/ml). Week 2 serum pools (IgM high, IgG3 low or undetectable) transferred substantial protection against 2308 (> or = 1 log unit) which increased relatively little (to 1.2-1.5 log units) with later sera that were high in IgG antibodies. In contrast, week 2 sera conferred low levels of protection against 19 (< 0.6 log units), but protection was dramatically increased (to > or = 2.3 log units) with sera obtained 1 week later that had slightly increased IgG antibodies. Monoclonal IgM antibodies also provided better protection against 2308 than 19, while monoclonal IgG3 antibodies protected much better against 19. Strain 19 opsonized with antibodies taken at any stage of infection was killed within normal macrophages, whereas comparably opsonized 2308 underwent intracellular replication. Phagocytosis of 2308 was better than of 19 when brucellae were opsonized with either polyclonal IgM or IgG3 antibodies, and the difference between strains was more extreme following IgM opsonization. The data suggest an explanation for differences in the growth curves of 2308 and 19 in spleens of BALB/c mice. Higher numbers achieved by 19 at week 2 could result from extracellular replication owing to ineffectual opsonization by IgM antibodies, while the precipitous decline of 19 beginning at week 3 could be caused by the increase in more effective IgG3 opsonins that facilitate its rapid intracellular destruction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7835931      PMCID: PMC1414908     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  Kinetic studies of a quantitative single-tube enzyme-linked immunosorbent assay.

Authors:  V C Tsang; B C Wilson; S E Maddison
Journal:  Clin Chem       Date:  1980-08       Impact factor: 8.327

2.  Immunochemical characterization of rough Brucella lipopolysaccharides.

Authors:  E Moreno; L M Jones; D T Berman
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

3.  Iron augments macrophage-mediated killing of Brucella abortus alone and in conjunction with interferon-gamma.

Authors:  X Jiang; C L Baldwin
Journal:  Cell Immunol       Date:  1993-05       Impact factor: 4.868

4.  Induction of immune and adjuvant immunoglobulin G responses in mice by Brucella lipopolysaccharide.

Authors:  E Moreno; R S Kurtz; D T Berman
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

5.  Comparison of sodium dodecyl sulfate-polyacrylamide gel electrophoresis profiles and antigenic relatedness among outer membrane proteins of 49 Brucella abortus strains.

Authors:  D R Verstreate; A J Winter
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

6.  Antigenic S-type lipopolysaccharide of Brucella abortus 1119-3.

Authors:  M Caroff; D R Bundle; M B Perry; J W Cherwonogrodzky; J R Duncan
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

7.  Serological cross-reactions between different Brucella species and Yersinia enterocolitica. Immunochemical studies on phenol-water extracted lipopolysaccharides from Brucella abortus and Yersinia enterocolitica type IX.

Authors:  B Hurvell; A A Lindberg
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1973-02

8.  Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica serotype O:9.

Authors:  M Caroff; D R Bundle; M B Perry
Journal:  Eur J Biochem       Date:  1984-02-15

9.  Outer membrane proteins of Brucella abortus: isolation and characterization.

Authors:  D R Verstreate; M T Creasy; N T Caveney; C L Baldwin; M W Blab; A J Winter
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

10.  Affinity purification of bovine antibodies to Brucella abortus Lipopolysaccharide.

Authors:  J M Stiller; K H Nielsen
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

View more
  22 in total

Review 1.  Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle.

Authors:  Arturo Casadevall
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

2.  Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival.

Authors:  C A Allen; L G Adams; T A Ficht
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

3.  Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK).

Authors:  D L Hoover; R M Crawford; L L Van De Verg; M J Izadjoo; A K Bhattacharjee; C M Paranavitana; R L Warren; M P Nikolich; T L Hadfield
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

4.  The HtrA stress response protease contributes to resistance of Brucella abortus to killing by murine phagocytes.

Authors:  P H Elzer; R W Phillips; G T Robertson; R M Roop
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

Review 5.  Antibodies for biodefense.

Authors:  Jeffrey W Froude; Bradley Stiles; Thibaut Pelat; Philippe Thullier
Journal:  MAbs       Date:  2011-11-01       Impact factor: 5.857

6.  The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice.

Authors:  Cyntia G M C Trant; Thais L S Lacerda; Natalia B Carvalho; Vasco Azevedo; Gracia M S Rosinha; Suzana P Salcedo; Jean-Pierre Gorvel; Sergio C Oliveira
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

7.  Immunization of mice with gamma-irradiated Brucella neotomae and its recombinant strains induces protection against virulent B. abortus, B. melitensis, and B. suis challenge.

Authors:  Dina Moustafa; Virendra K Garg; Neeta Jain; Nammalwar Sriranganathan; Ramesh Vemulapalli
Journal:  Vaccine       Date:  2010-11-23       Impact factor: 3.641

8.  Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice.

Authors:  Marie-Alice Vitry; Carl De Trez; Stanislas Goriely; Laure Dumoutier; Shizuo Akira; Bernhard Ryffel; Yves Carlier; Jean-Jacques Letesson; Eric Muraille
Journal:  Infect Immun       Date:  2012-09-24       Impact factor: 3.441

9.  O-Polysaccharide epitopic heterogeneity at the surface of Brucella spp. studied by enzyme-linked immunosorbent assay and flow cytometry.

Authors:  A Cloeckaert; V Weynants; J Godfroid; J M Verger; M Grayon; M S Zygmunt
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

10.  Variation of Brucella abortus 2308 infection in BALB/c mice induced by prior vaccination with salt-extractable periplasmic proteins from Brucella abortus 19.

Authors:  G W Pugh; L B Tabatabai
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.